Nutrition
Volume 26, Issue 1 , Pages 100-105 , January 2010

Moderate alcohol intake is associated with decreased risk of insulin resistance among individuals with vitamin D insufficiency

Received 21 October 2008 ,Accepted 26 March 2009.

References 

  1. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001;86:3574–3578
  2. Wilson WF, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:S3066–S3072
  3. Need AG, O'Loughlin PD, Horowitz M, Nordin BEC. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol 200;62:738–741.
  4. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia. 1997;40:344–347
  5. Scragg R, Sowers MF, Colin B. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813–2818
  6. Fuchs FD, Chambless LE, Folsom AR, Eigenbrodt ML, Duncan BB, Gilbert A, et al. Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2004;160:466–474
  7. Camargo CA, Stampfer MJ, Glynn RJ, Grodstein F, Gaziano JM, Manson JE, et al. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med. 1997;126:372–375
  8. Rehm JT, Bondy SJ, Sempos CT, Vuong CV. Alcohol consumption and coronary heart disease morbidity and mortality. Am J Epidemiol. 1997;146:495–501
  9. Tolstrup J, Jensen MK, Tjonneland A, Overad K, Mukamul KJ, Gronback M. Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ. 2006;332:1244–1248
  10. Femia R, Natali A, L'Abbate A, Ferrannini E. Coronary atherosclerosis and alcohol consumption: angiographic and mortality data. Arterioscler Thromb Vasc Biol. 2006;26:1607–1612
  11. Mukamul KJ, Chiuve SE, Rimm EB. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med. 2006;166:2145–2150
  12. Malinski MK, Sesso HD, Lopez-Jimenez F, Burning GE, Gaziano JM. Alcohol consumption and cardiovascular disease mortality in hypertensive men. Arch Intern Med. 2004;164:623–628
  13. King DE, Mainous AG, Geesey ME. Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events. Am J Med. 2008;121:201–206
  14. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck Study). BMJ. 1996;313:1040–1044
  15. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women. JAMA. 2002;287:2559–2562
  16. Kroenke CH, Chu NF, Rifai N, Spiegelman D, Hankinson SE, Manson JE, et al. A Cross sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care. 2003;26:1971–1978
  17. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI. Alcohol consumption and insulin resistance in young adults. Eur J Clin Invest. 2000;30:297–301
  18. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Ellison RC. Alcohol consumption and the prevalence of the metabolic syndrome in the U.S. A cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2954–2959
  19. National Center for Health Statistics. NHANES 1999–2000 data files. Available at: http://www.cdc.gov/nchs/about/major/nhanes/currentnhanes.htm. Accessed May 13, 2009.
  20. National Center for Health Statistics. Analytic guidelines. June 2004. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_general_guidelines_june_04.pdf. Accessed May 13, 2009.
  21. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460–464
  22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin. Diabetologia. 1985;28:412–419
  23. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320–3325
  24. Levis S, Gomez A, Jiminez C, Veras L, Ma F, Lai B, et al. Vitamin D deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005;90:1557–1562
  25. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135:317–322
  26. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–825
  27. Lind L, Heanni A, Lithell H, Hvarfner A, Seorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995;8:894–901
  28. Banini AE, Boyd LC, Allen JC, Allen HG, Sauls DL. Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects. Nutrition. 2006;22:1137–1145
  29. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980–986
  30. De Boer IH, Tinker LF, Connelly S, Curb D, Howard BV, Kestenbaum B, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008;31:701–707
  31. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629–1637
  32. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, DeLuca HF. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology. 1983;113:1511–1518
  33. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823–825
  34. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D deficient rat in vivo. Endocrinology. 1986;119:84–90
  35. Ayesha I, Bala TS, Reddy CV, Raghjuramulu N. Vitamin D deficiency reduces insulin secretion and turnover in rats. Diabetes Nutr Metab. 2001;14:78–84
  36. Bourlon PM, Faure-Dussert A, Billaudel B. The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1,25-dihydroxyvitamin D3 repletion in the islets of Langerhans of rats. J Endocrinol. 1999;162:101–109
  37. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771–777

 This study supported in part by grant 5 D55HP05150 from the Health Resources and Services Administration.

PII: S0899-9007(09)00140-3

doi: 10.1016/j.nut.2009.03.006

Nutrition
Volume 26, Issue 1 , Pages 100-105 , January 2010

Article Tools